{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-032599","form_type":"8-K","ticker":"RNGE","cik":"0001438943","company_name":"RANGE IMPACT, INC.","filed_at":"2021-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.594952+00:00","generated_at":"2026-06-27T22:06:20.590538+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Malachite Innovations announces two USPTO patents granted for cannabinoid prodrugs and antimicrobials; new PCT filing","bullets":["U.S. Patent granted for 'Cannabinoid Glycoside Prodrugs and Methods of Synthesis' covering 18 distinct cannabinoid glycosides for treating IBD and IBS.","Second U.S. Patent granted for 'Antimicrobial Composition Comprising Cannabinoids' covering CBD/THC against C. diff, VRE, and S. pneumoniae.","New PCT patent application filed for 'Continuous Enzymatic Perfusion Reactor System' to improve glycoside manufacturing; preserves rights in 153 countries.","Patents based on 2016 and 2018 PCT filings, solidifying company's pioneer position in cannabinoid prodrugs without psychoactive effects.","Subsidiary Graphium Biosciences holds patents; additional divisional applications are being pursued."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-032599","json":"https://secwatch.observer/filing/0001493152-21-032599.json","markdown":"https://secwatch.observer/filing/0001493152-21-032599.md","text":"https://secwatch.observer/filing/0001493152-21-032599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438943/000149315221032599/0001493152-21-032599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438943/000149315221032599/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:06:20.590538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}